...
首页> 外文期刊>Journal of Surgical Oncology >Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.
【24h】

Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.

机译:全腹腔结肠切除术,盆腔腹膜切除术和回肠造口术用于缓解非妇科癌性粘液性腹膜癌的手术。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND AND OBJECTIVES: The optimal management of symptomatic advanced peritoneal carcinomatosis of non-gynecologic origin is not defined. Historic controls of surgical efforts report high postoperative mortality and morbidity rates with equivocal palliation. Novel surgical procedures need to be tested in terms of the impact on survival and quality of life. STUDY DESIGN: We studied 46 consecutive patients who underwent total abdominal colectomy, pelvic peritonectomy with construction of an end-ileostomy for palliation of peritoneal carcinomatosis. RESULTS: Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy was successfully performed in 46 patients of median age of 54.4 years. Overall median survival was 10.7 months, with a mean follow-up period of 12 months. Patients with appendiceal malignancy had a median survival of 19.7 months. Prognosis was poorer for patients with colon cancer, who had a median survival of 7.0 months, while patients with primary peritoneal carcinomatosis had a median of 7.8 months. Postoperative morbidity and mortality rates were 19.5 and 8.6%, respectively. CONCLUSIONS: Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy is a technically feasible procedure and is advocated for the palliation of patients with peritoneal carcinomatosis of appendiceal origin. It is not clear if the procedure should be advocated for more invasive gastrointestinal malignancies.
机译:背景与目的:未明确非妇科症状性晚期腹膜癌的最佳治疗方法。历史上对外科手术努力的控制表明,术后死亡率和发病率很高,而且模棱两可。需要就对生存和生活质量的影响测试新颖的外科手术程序。研究设计:我们研究了46例连续接受全结肠结肠切除术,盆腔腹膜切除术并通过回肠造口术减轻腹膜癌变的患者。结果:46例中位年龄为54.4岁的患者成功进行了全腹腔结肠切除术,盆腔腹膜切除术和回肠造口术。总体中位生存期为10.7个月,平均随访期为12个月。阑尾恶性肿瘤患者的中位生存期为19.7个月。结肠癌患者的中位生存期中位数为7.0个月,而原发性腹膜癌病患者的中位生存期为7.8个月,预后较差。术后发病率和死亡率分别为19.5和8.6%。结论:全腹结肠切除术,盆腔腹膜切除术和回肠造口术是一种技术上可行的方法,被提倡用于阑尾源性腹膜癌患者的缓解。目前尚不清楚是否应提倡对更具侵入性的胃肠道恶性肿瘤进行手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号